Moody National Bank Trust Division Acadia Pharmaceuticals Inc Transaction History

Moody National Bank Trust Division

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 22, 2019	SELL	$23.32 - $28.12 $3,871 - $4,667	-166 Closed	0 $0
Q1 2019 Apr 11, 2019	SELL	$16.17 - $27.38 $1,228 - $2,080	-76 Reduced 31.4%	166 $4,000
Q4 2018 Jan 07, 2019	BUY	$14.32 - $22.92 $3,465 - $5,546	242 New	242 $4,000

326

166M

855K

350K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.32B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Moody National Bank Trust Division, based on Form 13F filings with the SEC.

Stay updated on Moody National Bank Trust Division with notifications on news.